Vitamin D deficiency is associated with lipid metabolism disorders, in particular, with an increase in TG and a decrease in HDL-C, as well as with LADA decompensation, which indicates the need for its normalization in this type of diabetes regardless of the phen...
Prevalence and pattern of dyslipi- demia in type 2 diabetes mellitus patients in a rural tertiary care centre, southern India. Glob J Med Public Health. 2012;1:24-7.Jayarama N, Madhavi Reddy, Lakshmaiah V, et al. Prevalence and pattern of dyslipidemia in type 2 diabetes mellitus ...
To explore the relationship between serum thyroid-stimulating hormone (TSH) and dyslipidemia.A total of 1 512 inhabitants in Zhaiji community of Guiyang urban areas were investigated from November 2009 to February 2010 by adopting stratified cluster sampling method, and 1 428 subjects were included ...
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus Nat. Rev. Endocrinol., 17 (2021), pp. 484-495 CrossrefView in ScopusGoogle Scholar 17 M. Stepanova, N. Rafiq, H. Makhlouf, R. Agrawal, I. Kaur, Z. Younoszai, et al. Predictors of all-cause mo...
Turnbaugh, P.J.; Ley, R.E.; Mahowald, M.A.; Magrini, V.; Mardis, E.R.; Gordon, J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444, 1027–1031. [CrossRef] 19. Ley, R.E.; Turnbaugh, P.J.; Klein, S.; ...
Brensike J.F., Levy R.I., Kelsey S.F., et al.: Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI type II coronary intervention study. Circulation 69, 313–324, 1984. CrossRef Blankenhorn D.H., Nessim S.A., Johnson R.L., Sanmar...
: Amvrosieva T.V., Votyakov V.I., Cheschevik A.B., Gudkov V.G., Andreeva O.T., Novikova I.E., Orlova S.V., Zgyrovskaya A.A. Byelorussian Research Institute for Epidemiology & Microbiology, Minsk, Republic of BelarusShow moreShow less...
Decreasing trend of blood lipid profile in type 2 diabetes: Not a promising change in HDL-C, a serial cross-sectional study Background: The prevalence of dyslipidemia in patients with type 2 diabetes (T2D) has been reported to be relatively high. The current study aimed to inves... A Yade...
A TelentiP SudreJ J CheseauxV MooserCirculationPeriard D, Telenti A, Sudre P, et al. Atherogenic dyslipidemia in HIV-infected in- dividuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circula-...
Doser N, Sudre P, Telenti A, Wietlisbach V, Nicod P, Darioli R, Mooser V: Persistent dyslipidemia in HIV-infected individuals switched from a protease inhibitor-containing to an efavirenz-containing regimen. JAIDS 2001, 26(4):389-390....